Driven by diligence
Canara Robeco's Cheenu Gupta believes in knowing her companies inside out, and never being too sure of one’s analysis
Anishaa Kumar - March 01, 2021
When the sun shines
Non-executive director Sudhir Valia sells Sun Pharma stock worth ₹2.91 billion held by Raksha Valia
Shailaja Mohapatra - January 16, 2021
When Wind Met Sun
In 2015, Dilip Shanghvi raised eyebrows when he invested Rs.18 billion in Suzlon
Krishna Gopalan - July 18, 2020
What does Rakesh Jhunjhunwala see in Jubilant Life Sciences?
Within a year, the investing legend has doubled down on his latest pharma bet
Himanshu Kakkar - May 23, 2020
New growth model
Indian pharma majors are facing their toughest year yet in the US, with regulatory clampdown, hostile political environment and falling prices. Is reinvention the answer to their woes?
Kripa Mahalingam - July 26, 2019
Tricky Transition
Generic Indian pharma players are changing their formula to focus on high-margin complex generics and specialty drugs
N Mahalakshmi - July 16, 2019
The Eclipse of A Star
Investors worry about poor corporate governance practices at Sun Pharma and price erosion in the US generics market
Prathamesh Mulye - March 25, 2019
Content Farming
OTT players are splurging on 'Originals' to stay ahead
N Mahalakshmi - March 18, 2019
Seeking a Safe Haven
As the market tumbles, mutual fund managers recommend pharma, private banks and specialty chemicals to tide over the volatility
Prathamesh Mulye - January 08, 2019
Uphill Climb
The pharma industry has to deal with poor road connectivity and an unskilled labour force in Sikkim, but it seems to have made peace with the mountains
Himanshu Kakkar - January 25, 2019
